Cas:895042-38-3 3-(4-Methylphenyl)-1H-pyrazol-5-amine manufacturer & supplier

Chemical Name:3-(4-Methylphenyl)-1H-pyrazol-5-amine

CAS.NO:895042-38-3

Synonyms:3-(4-Methylphenyl)-1H-pyrazol-5-amine

Molecular Formula:C₁₀H₁₁N₃

Molecular Weight:173.21400

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:55.43000

Exact Mass:173.09500

LogP:1.89740

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 3-(4-Methylphenyl)-1H-pyrazol-5-amine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-(4-Methylphenyl)-1H-pyrazol-5-amine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-(4-Methylphenyl)-1H-pyrazol-5-amine Use and application,3-(4-Methylphenyl)-1H-pyrazol-5-amine technical grade,usp/ep/jp grade.

Related News: Compared with existing Imbruvica therapies, where patients take the BTK inhibitor daily—potentially for years—until their disease progresses, the new Venclexta combo caps treatment at about 14 months. That could offer a new option for “probably younger patients with CLL that prefer more flexible, treatment-free intervals,” said Craig Tendler, M.D., vice president of oncology clinical development and global medical affairs at J&J’s Janssen unit, during an interview. 3-(4-Methylphenyl)-1H-pyrazol-5-amine manufacturer No amount of unmet need can take the place of sufficient evidence, said Johns Hopkins public health professor Dr. Caleb Alexander, a member of the FDA advisory panel. 3-(4-Methylphenyl)-1H-pyrazol-5-amine supplier Oligomannate, which uses extract from marine brown algae as raw material, received a conditional green light to treat mild-to-moderate level AD, the National Medical Products Administration (NMPA) said in a statement on its website late on Saturday. 3-(4-Methylphenyl)-1H-pyrazol-5-amine vendor Rigosertib, Onconova��s lead candidate, is a proprietary Phase 3 small molecule. 3-(4-Methylphenyl)-1H-pyrazol-5-amine factory Oligomannate, which uses extract from marine brown algae as raw material, received a conditional green light to treat mild-to-moderate level AD, the National Medical Products Administration (NMPA) said in a statement on its website late on Saturday.